Institutional Manager · CIK 0001903793
TPG GP A, LLC
Fort Worth, TX · File #028-22121
Latest AUM
$2.69B
Positions
10
Top-10 Concentration
100.0%
Filings
11
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | BETA Technologies Inc | BETA | +16,395,435 | +$462.5M | $0 |
| REDUCE | Allogene Therapeutics Inc | ALLO | 0 | $0 | +$2.4M |
| REDUCE | Amneal Pharmaceuticals Inc | AMRX | 0 | $0 | +$31.9M |
| REDUCE | Bicara Therapeutics Inc. | BCAX | 0 | $0 | +$3.1M |
| REDUCE | CeriBell Inc. | CBLL | 0 | $0 | +$41.4M |
| REDUCE | Life Time Group Holdings Inc | LTH | 0 | $0 | -$18.2M |
| REDUCE | LifeStance Health Group Inc | LFST | 0 | $0 | +$247.5M |
| REDUCE | Rallybio Corp | RLYB | 0 | $0 | +$575,399 |
| REDUCE | Sionna Therapeutics Inc | SION | 0 | $0 | +$79.1M |
| REDUCE | TPG RE Fin Tr Inc | TPGXL | 0 | $0 | +$119,643 |
Sector Allocation
Filing History
- 13F COMBINATION REPORTQ/E Dec 202510 pos · $2.69B
- 13F COMBINATION REPORTQ/E Sep 20259 pos · $1.84B
- 13F COMBINATION REPORTQ/E Jun 20259 pos · $1.88B
- 13F COMBINATION REPORTQ/E Mar 202528 pos · $5.07B
- 13F COMBINATION REPORTQ/E Dec 202431 pos · $6.20B
- 13F COMBINATION REPORTQ/E Sep 202435 pos · $5.87B
- 13F COMBINATION REPORT (Amended)Q/E Sep 20241 pos · $2.06B
- 13F COMBINATION REPORT (Amended)Q/E Jun 202434 pos · $5.22B
- 13F COMBINATION REPORTQ/E Jun 202433 pos · $4.36B
- 13F COMBINATION REPORTQ/E Mar 202434 pos · $5.22B
- 13F HOLDINGS REPORTQ/E Dec 202337 pos · $5.80B
Top 10 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | LifeStance Health Group Inc | LFST | 160,711,618 | $1.13B | 42.11% |
| 2 | Life Time Group Holdings Inc | LTH | 17,830,652 | $473.9M | 17.64% |
| 3 | BETA Technologies Inc | BETA | 16,395,435 | $462.5M | 17.22% |
| 4 | Sionna Therapeutics Inc | SION | 6,744,962 | $277.5M | 10.33% |
| 5 | Amneal Pharmaceuticals Inc | AMRX | 12,328,767 | $155.3M | 5.78% |
| 6 | CeriBell Inc. | CBLL | 3,967,422 | $87.0M | 3.24% |
| 7 | Bicara Therapeutics Inc. | BCAX | 3,010,425 | $50.7M | 1.89% |
| 8 | Allogene Therapeutics Inc | ALLO | 18,716,306 | $25.6M | 0.95% |
| 9 | TPG RE Fin Tr Inc | TPGXL | 2,392,863 | $20.6M | 0.77% |
| 10 | Rallybio Corp | RLYB | 3,028,414 | $2.1M | 0.08% |